Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025International Journal of Molecular SciencesOpen Access

Dysregulation of MicroRNAs in Hepatocellular Carcinoma: Targeting Oncogenic Signaling Pathways for Innovative Therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYusra ZarlashatJHJudit HalászEDEdit Dósa

Discussion

Loading...

Member takes

Overview

Review reveals microRNAs regulate oncogenic signaling pathways in hepatocellular carcinoma, suggesting novel therapies.

Key Points

  • Dysregulation of microRNAs can promote tumor growth and treatment resistance in hepatocellular carcinoma.
  • Preclinical studies show that targeting specific microRNAs can effectively reduce HCC progression and improve survival rates.
  • Strategies like restoring tumor-suppressive microRNAs or inhibiting oncogenic ones can enhance HCC therapy outcomes.
  • Combination therapies utilizing nanoparticles to deliver specific microRNAs show promise for treating HCC.

Cite This Study

Zarlashat et al. (2025) studied this question.

synapsesocial.com/papers/68c23922b210217d6477b141https://doi.org/10.3390/ijms26178365
View Full Paper
Ask AI
Bookmark
Share